Synopsis
Motivation:
Goals:
Approach:
Results:
551-03-006 / 551-03-006
ISMRM Abstract
Glymphatic Dysfunction and Lifespan Trajectories Across Neuropsychiatric Disorders Revealed by DTI-ALPS
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Farsi Z, Sheng M. Molecular mechanisms of schizophrenia: Insights from human genetics. Current Opinion in Neurobiology. 2023 Aug 1;81:102731. DOI: 10.1016/j.conb.2023.102731. [doi]
2. Ling E, Nemesh J, Goldman M, Kamitaki N, Reed N, Handsaker RE, Genovese G, Vogelgsang JS, Gerges S, Kashin S, Ghosh S. A concerted neuron–astrocyte program declines in ageing and schizophrenia. Nature. 2024 Mar 21;627(8004):604-11. DOI: 10.1038/s41586-024-07109-5. [doi]
3. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Science translational medicine. 2012 Aug 15;4(147):147ra111-. doi: 10.1126/scitranslmed.3003748. [doi]
4. Gao Y, Liu K, Zhu J. Glymphatic system: an emerging therapeutic approach for neurological disorders. Frontiers in Molecular Neuroscience. 2023 Jul 6;16:1138769. doi: 10.3389/fnmol.2023.1138769. [doi]
5. Barlattani T, Grandinetti P, Cintio AD, Montemagno A, Testa R, D'Amelio C, Olivieri L, Tomasetti C, Rossi A, Pacitti F, De Berardis D. Glymphatic system and psychiatric disorders: a rapid comprehensive scoping review. Current Neuropharmacology. 2024 Oct 1;22(12):2016-33. DOI: https://doi.org/10.2174/1570159X22666240130091235. [doi]
6. Taoka T, Masutani Y, Kawai H, Nakane T, Matsuoka K, Yasuno F, Kishimoto T, Naganawa S. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease cases. Japanese journal of radiology. 2017 Apr;35(4):172-8. DOI: https://doi.org/10.1007/s11604-017-0617-z. [doi]
7. Tu Y, Fang Y, Li G, Xiong F, Gao F. Glymphatic system dysfunction underlying schizophrenia is associated with cognitive impairment. Schizophrenia Bulletin. 2024 Sep;50(5):1223-31. doi: 10.1093/schbul/sbae039. [doi]
8. AAbdolizadeh A, Torres-Carmona E, Kambari Y, Amaev A, Song J, Ueno F, Koizumi T, Nakajima S, Agarwal SM, De Luca Abdolizadeh A, Torres-Carmona E, et al. Evaluation of the glymphatic system in schizophrenia spectrum disorder using proton magnetic resonance spectroscopy measurement of brain macromolecule and diffusion tensor image analysis along the perivascular space index. Schizophrenia Bulletin. 2024 Nov;50(6):1396-410. doi: 10.1093/schbul/sbae060. [doi]
9. Senra Filho A. C. da S., von Glehn F., Cendes F., Yasuda C. L., and Paschoal A. M. DTI-ALPS index as complementary information for Neuromyelitis Optica patients: a preliminary evaluation. ISMRM & ISMRT Annual Meeting, 2025.
10. Senra Filho A. C. da S., Fillion-Robin J.-C., Butler J. Slicer-DTI-ALPS software. Available at: https://slicer-dti-alps.readthedocs.io/en/latest/.
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/551-03-006